title: Bortezomib-based antibody reduction therapy: the first step to “true” desensitization?
authors.forename: K
authors.initials: K
authors.lastname: Budde
authors.forename: L J
authors.initials: LJ
authors.lastname: Lehner
mesh_terms: D001897:Boronic Acids / Q000627:therapeutic use*; D003888:Desensitization, Immunologic; D005260:Female; D006084:Graft Rejection / Q000276:immunology*; D006085:Graft Survival / Q000276:immunology*; D006680:HLA Antigens / Q000276:immunology*; D006801:Humans; D007674:Kidney Diseases / Q000276:immunology*; D008297:Male; D061988:Proteasome Inhibitors / Q000627:therapeutic use*; D011719:Pyrazines / Q000627:therapeutic use*
chemical_list: D001897:Boronic Acids; D006680:HLA Antigens; D061988:Proteasome Inhibitors; D011719:Pyrazines